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             Atrial fibrillation (AF) is a very undesirable, but unfortunately a common arrhythmia
following coronary artery bypass graft (CABG) surgery, occurring in up to 40% of patients1.
There is an increase in hospital stay2 and adds to the overall cost of the surgery. Atrial fibrillation
occurrence may identify a subset of patients with reduced survival3. Prevention of AF therefore
would have a significant positive impact on patients undergoing CABG surgery.
            The pathophysiology of post-operative AF is incompletely understood and appears multi-
factorial. There are studies to suggest clinical factors like advanced age, prior history of AF4,
post-operative withdrawal of beta-blocker or an angiotensin-converting enzyme (ACE) inhibitor,
chronic obstructive lung disease predicting post-operative AF5. P-wave duration, increase in P
wave dispersion6, postoperative low cardiac output, preoperative larger left atrium (LA) and LA
appendage area, a lower LA ejection fraction, post-bypass atrial systolic dysfunction and
abnormal relaxation of the left ventricle, higher preoperative heart rate, increased pulmonary
capillary  wedge   pressure7,   also   predicts   postoperative   AF.   It  has   been   implicated   that
endogenously released adenosine has a role for triggering early (< 48 hr) post-CABG AF8.
Another issue that received attention was the role of on-pump or off-pump bypass surgery,
wherein no significant influence of either on the incidence of postoperative AF could be
definitively established9. There are two opinions about the change in the autonomic tone brought
about by dissection of the anterior epicardial fat or the aortic fat pad influencing the incidence of
post CABG AF10. 
            It is crucial to identify who would be at risk of developing AF, post CABG surgery, so as
to institute appropriate preventive measures. Pharmacological approach has been widely used
wherein preoperative initiation of beta-blocker therapy like oral metoprolol and continuation of
the same postoperatively has been very effective in preventing AF11. Amiodarone, sotalol and
propafenone have also been studied. Atrial Fibrillation Suppression Trial (AFIST)12 showed that
oral amiodarone prophylaxis in combination with beta-blockers prevents atrial fibrillation and
reduces the risk of cerebrovascular accidents. Similarly in patients with chronic obstructive
pulmonary   disease,   where   beta-blockers   would   be   contraindicated,   early   prophylactic
amiodarone was found to reduce AF incidence13. Amiodarone and sotalol were found to have
similar efficacy and safety in reducing postoperative AF. However, in patients undergoing more
complex   surgery,   postoperative   AF   occurred   more   frequently   with   sotalol   than   with
amiodarone14. 
            Based on the mechanism of postoperative AF, it seems likely that overcoming the slow
atrial conduction with reduction in the dispersion of atrial refractoriness and suppression of the
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atrial ectopy should prevent AF. With these considerations atrial overdrive pacing to prevent
post CABG AF has been evaluated with a number of randomized, controlled trials. These trials
compared controls with either single site atrial pacing i.e. right atrial pacing (RAP) or left atrial
pacing (LAP) and biatrial pacing (BAP) or only RAP and BAP or only LAP and BAP.
Bachmann’s bundle pacing as an alternative to two sites, biatrial pacing has also been studied.
Different pacing modalities (AAT, AAI, DDD, atrial overdrive algorithms) and different
stimulation rates are initiated after the surgery and continued for a period of 3-4 days. Earlier
studies with pacing highlighted the limitations including sensing and capture problems, increase
in atrial ectopy with demand (AAI) pacing and reported no advantage with pacing. However,
most recent studies seem to favor prophylactic biatrial pacing to reduce the incidence of post
CABG AF15. Two studies, one by Goette et al16 and the other, AFIST II17 show no impact on
post-operative AF. Goette et al studied the role of Bachmann's bundle (BB) pacing, and required
early termination of pacing in 16% of patients because of rise in thresholds. The AFIST II
evaluated the prophylactic use of a hybrid intravenous and oral amiodarone regimen, atrial septal
pacing, or both strategies in post-cardiothoracic surgery (inclusive of valve surgeries) patients. A
hybrid intravenous and oral amiodarone regimen was effective at decreasing the incidence of
post-operative AF, but atrial septal pacing was found to be ineffective. However, patients
receiving both amiodarone and pacing had significantly lower AF rates than those receiving
placebo with or without pacing. 
            The present study involving 120 patients by Massoud E. et al18 in the present issue is one
more study evaluating the role of biatrial pacing in prevention of AF after CABG surgery. This is
a prospective, randomized, double blinded-placebo controlled study comparing biatrial pacing
with LA pacing and no pacing. The baseline characteristics especially age, LV function, use of
beta-blockers, perfusion time and cross-clamp time were well matched in the three groups. Atrial
fibrillation occurred in 17.5% patients with bi-atrial pacing, compared to 30% in the LA pacing
(p=0.04) and 45% in the control group (p=0.02). Consequently the duration of stay in the
intensive care unit and the total hospital stay was significantly reduced in the biatrial-pacing
group. The complications were no different between the groups. The time to occurrence and
duration of AF was also similar in the three groups. They conclude two sites, biatrial pacing as
well tolerated and effective in preventing AF and thereby shorten hospital stay. 
            It seems use of oral beta-blockers preoperatively and continuing the same postoperatively
definitely prevents AF occurrences in the post-operative patients. Amiodarone therapy is
especially rewarding when a hybrid intravenous and oral loading regime is employed as
suggested by AFIST II trial. A meta-analysis of smaller pacing studies support the role of biatrial
pacing. Few questions remain unanswered. Is pacing a cost-effective strategy; should it be
prophylactically used in all patients; is there at all a role of single chamber (RA or LA) pacing
and single site biatrial pacing (Bachmann bundle or atrial septal pacing)? A larger, multi-center
study with a cost effective analysis, over and above the use of beta-blocker and amiodarone is
likely to settle the role of prophylactic pacing. Till such time we need to pre-select the high-risk
group and offer biatrial pacing. 
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